Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukaemia

European Journal of Haematology

Volumn 92, Issue 4, 2014, Pages 321-330

  Lund, Bendik ^a,b   Wesolowska Andersen, Agata ^c   Lausen, Birgitte ^d   Borst, Louise ^d   Rasmussen, Kirsten Kørup ^d   Müller, Klaus ^d   Klungland, Helge ^b   Gupta, Ramneek ^c   Schmiegelow, Kjeld ^d,e  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d University of Copenhagen   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Childhood leukaemia; Immunogenetics; Infection; Pharmacogenetics; Single nucleotide polymorphisms

Indexed keywords

ASPARAGINASE; BILE ACID; BILE SALT; COTRIMOXAZOLE; DOXORUBICIN; EOTAXIN; G PROTEIN COUPLED RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METHOTREXATE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIGEN PRESENTATION; ARTICLE; BILE ACID METABOLISM; BLOOD; BLOOD CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAZARD RATIO; HOST; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PHARMACOGENOMICS; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK FACTOR; SCHOOL CHILD; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; GENETICS; GENOMICS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC VARIATION; GENOMICS; HUMANS; INFANT; INFECTION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK; TREATMENT OUTCOME;

EID: 84896542756     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12243     Document Type: Article

References (47)

1. Lund B, Asberg A, Heyman M, Kanerva J, Harila-Saari A, Hasle H, Soderhall S, Jonsson OG, Lydersen S, Schmiegelow K. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 2011;56:551-9.
2. Lausen B, Schmiegelow K, Andreassen B, Madsen HO, Garred P. Infections during induction therapy of childhood acute lymphoblastic leukemia-no association to mannose-binding lectin deficiency. Eur J Haematol 2006;76:481-7.
3. Afzal S, Ethier MC, Dupuis LL, Tang L, Punnett AS, Richardson SE, Allen U, Abla O, Sung L. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia. Pediatr Infect Dis J 2009;28:1064-8.
4. Prucker C, Attarbaschi A, Peters C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group. Leukemia 2009;23:1264-9.
5. Bailey LC, Reilly AF, Rheingold SR. Infections in pediatric patients with hematologic malignancies. Semin Hematol 2009;46:313-24.
6. Rahiala J, Perkkio M, Riikonen P. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients. Pediatr Hematol Oncol 1998;15:165-74.
7. Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G, Lemon D, Hunt WC, Winter SS. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53-8.
8. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-9.
9. Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007;45:1296-304.
10. Sung L, Gamis A, Alonzo TA, Buxton A, Britton K, Deswarte-Wallace J, Woods WG. Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia. Cancer 2009;115:1100-8.
11. Kidas E, Moricke A, Beier R, Welte K, Schrappe M, Stanulla M, Grigull L. Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study. Int J Hematol 2009;89:584-91.
12. Miedema KG, te Poele EM, Tissing WJ, Postma DS, Koppelman GH, de Pagter AP, Kamps WA, Alizadeh BZ, Boezen HM, de Bont ES. Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia. Leukemia 2011;25:995-1000.
13. Lehrnbecher T, Bernig T, Hanisch M, Koehl U, Behl M, Reinhardt D, Creutzig U, Klingebiel T, Chanock SJ, Schwabe D. Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 2005;19:1745-50.
14. Erdelyi DJ, Kamory E, Zalka A, et al. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia. Cell Immunol 2006;244:121-4.
15. Huttunen R, Aittoniemi J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect 2011;63:407-19.
16. Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ Jr, Faist E, Reinhart K. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003;31:1560-7.
17. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007;3:e98.
18. Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 2009;301:393-403.
19. Maher B. ENCODE: the human encyclopaedia. Nature 2012;489:46-8.
20. Wesolowska A, Dalgaard MD, Borst L, et al. Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia 2011;25:1001-6.
21. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000;14:2267-75.
22. Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Soderhall S, Taskinen M. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010;24:345-54.
23. Schmiegelow K, Pulczynska MK. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts? Am J Pediatr Hematol Oncol 1990;12:462-7.
24. Hubbard T, Barker D, Birney E, et al. The Ensembl genome database project. Nucleic Acids Res 2002;30:38-41.
25. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589-95.
26. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
27. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-60.
28. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010;26:2069-70.
29. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
30. Danecek P, Auton A, Abecasis G, et al. The variant call format and VCFtools. Bioinformatics 2011;27:2156-8.
31. Besag J, Clifford P. Sequential Monte Carlo p-values. Biometrika 1991;78:301-4.
32. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. Circos: an information aesthetic for comparative genomics. Genome Res 2009;19:1639-45.
33. Joshi-Tope G, Gillespie M, Vastrik I, et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 2005;33(Database issue):D428-32.
34. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics 2009;25:2078-9.
35. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the rpart routines. Technical report: Mayo Clinic, Rochester. http://www.mayo.edu/hsr/techrpt/61.pdf; 1997.
36. Schmiegelow K, Al-Modhwahi I, Andersen MK, et al. Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood 2009;113:6077-84.
37. Feldmesser E, Olender T, Khen M, Yanai I, Ophir R, Lancet D. Widespread ectopic expression of olfactory receptor genes. BMC Genomics 2006;7:121.
38. Otaki JM, Fearon DT, Yamamoto H. The proto-oncogene BCL-6 is expressed in olfactory sensory neurons. Neurosci Res 2005;53:189-200.
39. Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499:214-8.
40. Bains OS, Karkling MJ, Grigliatti TA, Reid RE, Riggs KW. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. Drug Metab Dispos 2009;37:1107-14.
41. Vallance K, Liu W, Mandrell BN, Panetta JC, Gattuso JS, Hockenberry M, Zupanec S, Yang L, Yang J, Hinds PS. Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer 2010;46:1848-55.
42. Avila J, Acosta E, Machargo MD, Arteaga MF, Gallego E, Canete H, Garcia-Perez JJ, Martin-Vasallo P. Autoantigenic nuclear proteins of a clinically atypical renal vasculitis. J Autoimmune Dis 2008;5:3.
43. Simons JE, Rothenberg ME, Lawrence RA. Eotaxin-1-regulated eosinophils have a critical role in innate immunity against experimental Brugia malayi infection. Eur J Immunol 2005;35:189-97.
44. Del Valle-Perez B, Martinez VG, Lacasa-Salavert C, Figueras A, Shapiro SS, Takafuta T, Casanovas O, Capella G, Ventura F, Vinals F. Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2. J Biol Chem 2010;285:10748-60.
45. Griffiths GS, Grundl M, Allen JS 3rd, Matter ML. R-Ras interacts with filamin a to maintain endothelial barrier function. J Cell Physiol 2011;226:2287-96.
46. Gaynon PS, Carrel AL. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol 1999;457:593-605.
47. Tasker JG, Di S, Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 2006;147:5549-56.